Purification and characterization of a tissue plasminogen activator-inhibitor complex from human umbilical vein endothelial cell conditioned medium
- 1 November 1987
- journal article
- research article
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 26 (23) , 7443-7449
- https://doi.org/10.1021/bi00397a037
Abstract
Tissue plasminogen activator-inhibitor complexes were purified from the conditioned medium of human umbilical vein endothelial cells by affinity chromatography followed by gel filtration. It was found that a single complex was isolated which can exist in two distinct interconvertible conformations. These may be separated by electrophoresis into a form with a 105,000 apparent molecular weight and a form with an 88,000 apparent molecular weight. The particular conformation which predominates may be altered by changing the pH at which preparations are incubated or by including dithiothreitol in incubation buffers. Plasminogen activator enzymatic activity may be partially recovered from purified complexes by incubation in the presence of fibrin. Incubation in 1.5 M NH4OH results in the dissociation of the complex into two major polypeptides of 67 and 40 kilodaltons (kDa). The 40-kDa protein was isolated by gel filtration high-pressure liquid chromatography. N-Terminal amino acid analysis of this protein revealed three distinct sequences. Two of these were nearly identical and matched the N-terminal sequence recently reported for the native plasminogen activator inhibitor from endothelial cells. The third sequence exactly matched an internal portion of the same protein. The results suggest that the internal sequence is located at the site where the inhibitor is cleaved by tissue plasminogen activator.This publication has 23 references indexed in Scilit:
- Plasma levels of a specific inhibitor of tissue-type plasminogen activator (and urokinase) in normal and pathological conditionsThrombosis Research, 1984
- Latent tissue plasminogen activator produced by human endothelial cells in culture: evidence for an enzyme-inhibitor complex.Proceedings of the National Academy of Sciences, 1983
- Evidence for a rapid inhibitor to tissue plasminogen activator in plasmaThrombosis Research, 1983
- An Enzyme Linked Immunosorbent Assay for Determination of Tissue Plasminogen Activator Applied to Patients with Thromboembolic DiseaseThrombosis and Haemostasis, 1983
- Plasminogen activator release during venous stasis and exercise as determined by a new specific assayClinica Chimica Acta; International Journal of Clinical Chemistry, 1983
- Silver stain for proteins in polyacrylamide gels: A modified procedure with enhanced uniform sensitivityAnalytical Biochemistry, 1981
- The interaction of α1-antitrypsin with trypsin, chymotrypsin and human leukocyte elastase as revealed by end group analysisBiochimica et Biophysica Acta (BBA) - Protein Structure, 1981
- Carboxy terminal fragment of human α-1-antitrypsin from hydroxylamine clevage: Homology with antithrombin IIIBiochemical and Biophysical Research Communications, 1979
- Human alpha-1-proteinase inhibitor mechanism of action: Evidence for activation by limited proteolysisBiochemical and Biophysical Research Communications, 1976
- Spectrophotometric determination of microgram quantities of protein without nucleic acid interferenceAnalytical Biochemistry, 1968